| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.959 | 0.002 | 0.959 | Prostaglandin antagonist | 0.863 0.003 CID_154699705 0.878 0.003 CID_154699496 | ||
| 0.947 | 0.002 | 0.947 | Prostaglandin D2 antagonist | 0.752 0.002 CID_154699705 0.782 0.002 CID_154699496 | ||
| 0.92 | 0.001 | 0.92 | Thromboxane antagonist | 0.913 0.001 CID_154699705 0.919 0.001 CID_154699496 | ||
| 0.917 | 0.001 | 0.917 | Thromboxane A2 antagonist | 0.91 0.001 CID_154699705 0.915 0.001 CID_154699496 | ||
| 0.909 | 0.003 | 0.909 | Platelet antagonist | 0.905 0.003 CID_154699705 0.903 0.003 CID_154699496 | ||
| 0.752 | 0.005 | 0.825 | Antithrombotic | 0.801 0.004 CID_154699705 0.825 0.004 CID_154699496 | CID_154699496 | |
| 0.727 | 0.005 | 0.756 | Platelet aggregation inhibitor | 0.756 0.004 CID_154699705 0.718 0.005 CID_154699496 | CID_154699705 | |
| 0.65 | 0.001 | 0.65 | Thromboxane synthase inhibitor | 0.361 0.003 CID_154699705 0.388 0.002 CID_154699496 | ||
| 0.507 | 0.002 | 0.507 | Prostacyclin antagonist | 0.349 0.003 CID_154699705 0.363 0.003 CID_154699496 | ||
| 0.382 | 0.001 | 0.382 | Prostaglandin H2 antagonist | 0.193 0.001 CID_154699705 0.209 0.001 CID_154699496 | ||
| 0.379 | 0.024 | 0.453 | Sodium/bile acid cotransporter inhibitor | 0.453 0.007 CID_154699705 0.453 0.007 CID_154699496 | CID_154699496 | |
| 0.35 | 0.02 | 0.35 | Non-steroidal antiinflammatory agent | 0.34 0.021 CID_154699705 0.301 0.028 CID_154699496 | ||
| 0.34 | 0.013 | 0.342 | Gastrin inhibitor | 0.312 0.026 CID_154699705 0.342 0.013 CID_154699496 | CID_154699496 | |
| 0.368 | 0.073 | 0.732 | Toll-Like receptor 7 agonist | 0.471 0.038 CID_154699705 0.732 0.007 CID_154699496 | CID_154699496 | |
| 0.361 | 0.077 | 0.725 | Toll-Like receptor agonist | 0.464 0.04 CID_154699705 0.725 0.007 CID_154699496 | CID_154699496 | |
| 0.373 | 0.107 | 0.378 | Cyclophilin D inhibitor | 0.378 0.104 CID_154699705 0.278 0.183 CID_154699496 | CID_154699705 | |
| 0.248 | 0.003 | 0.248 | Prostaglandin F2 alpha antagonist | 0.232 0.004 CID_154699705 0.232 0.004 CID_154699496 | ||
| 0.268 | 0.044 | 0.335 | Platelet adhesion inhibitor | 0.335 0.024 CID_154699705 0.314 0.029 CID_154699496 | CID_154699705 | |
| 0.284 | 0.086 | 0.295 | Interleukin 2 agonist | 0.295 0.077 CID_154699705 0.295 0.077 CID_154699496 | CID_154699496 | |
| 0.198 | 0.002 | 0.204 | Prostacyclin agonist | 0.198 0.002 CID_154699705 0.204 0.002 CID_154699496 | CID_154699496 | |
| 0.216 | 0.027 | 0.216 | Hexokinase inhibitor | 0.206 0.032 CID_154699705 0.206 0.032 CID_154699496 | ||
| 0.217 | 0.038 | 0.219 | Diuretic | 0.219 0.038 CID_154699705 0.161 0.068 CID_154699496 | CID_154699705 | |
| 0.237 | 0.074 | 0.258 | Hypolipemic | 0.258 0.064 CID_154699705 0.238 0.073 CID_154699496 | CID_154699705 | |
| 0.177 | 0.021 | 0.177 | Pregnane X receptor agonist | 0.157 0.041 CID_154699705 0.175 0.022 CID_154699496 | ||
| 0.164 | 0.009 | 0.185 | Prostaglandin EP2 antagonist | 0.185 0.007 CID_154699705 0.185 0.007 CID_154699496 | CID_154699496 | |
| 0.172 | 0.027 | 0.172 | GABA C receptor agonist | 0.107 0.06 CID_154699705 0.107 0.06 CID_154699496 | ||
| 0.14 | 0.006 | 0.14 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.114 0.009 CID_154699705 0.072 0.018 CID_154699496 | ||
| 0.189 | 0.057 | 0.189 | Antipruritic | 0.151 0.094 CID_154699705 0.155 0.089 CID_154699496 | ||
| 0.172 | 0.045 | 0.172 | Bone formation stimulant | 0.143 0.065 CID_154699705 0.139 0.068 CID_154699496 | ||
| 0.126 | 0.005 | 0.126 | Bombesin 3 receptor antagonist | 0.108 0.01 CID_154699705 0.057 0.035 CID_154699496 | ||
| 0.176 | 0.066 | 0.24 | Phospholipase C inhibitor | 0.24 0.027 CID_154699705 0.24 0.027 CID_154699496 | CID_154699496 | |
| 0.143 | 0.033 | 0.174 | CC chemokine 6 receptor antagonist | 0.174 0.006 CID_154699705 0.136 0.052 CID_154699496 | CID_154699705 | |
| 0.201 | 0.094 | 0.285 | Angiogenesis stimulant | 0.285 0.055 CID_154699705 0.285 0.055 CID_154699496 | CID_154699496 | |
| 0.19 | 0.084 | 0.19 | Histone acetyltransferase inhibitor | |||
| 0.216 | 0.115 | 0.225 | Transcription factor STAT3 inhibitor | 0.225 0.106 CID_154699705 0.225 0.106 CID_154699496 | CID_154699496 | |
| 0.217 | 0.122 | 0.217 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.301 | 0.215 | 0.604 | Antiinflammatory | 0.604 0.052 CID_154699705 0.422 0.126 CID_154699496 | CID_154699705 | |
| 0.087 | 0.006 | 0.087 | Prostaglandin EP3 antagonist | 0.062 0.008 CID_154699705 0.062 0.008 CID_154699496 | ||
| 0.117 | 0.039 | 0.117 | Electrolyte absorption antagonist | 0.086 0.082 CID_154699705 0.086 0.082 CID_154699496 | ||
| 0.076 | 0.004 | 0.079 | Prostaglandin D2 agonist | 0.079 0.004 CID_154699705 0.079 0.004 CID_154699496 | CID_154699496 | |
| 0.185 | 0.121 | 0.224 | Peptidyltransferase inhibitor | 0.224 0.072 CID_154699705 0.224 0.072 CID_154699496 | CID_154699496 | |
| 0.157 | 0.095 | 0.313 | Lipocortins synthesis antagonist | 0.313 0.019 CID_154699705 0.313 0.019 CID_154699496 | CID_154699496 | |
| 0.098 | 0.039 | 0.098 | Metalloproteinase-2 inhibitor | |||
| 0.232 | 0.174 | 0.279 | Antiobesity | 0.213 0.194 CID_154699705 0.279 0.132 CID_154699496 | CID_154699496 | |
| 0.07 | 0.013 | 0.07 | Secretase gamma inhibitor | |||
| 0.216 | 0.158 | 0.38 | Vasodilator, peripheral | 0.38 0.062 CID_154699705 0.295 0.099 CID_154699496 | CID_154699705 | |
| 0.21 | 0.155 | 0.279 | Caspase 3 stimulant | 0.279 0.09 CID_154699705 0.279 0.09 CID_154699496 | CID_154699496 | |
| 0.108 | 0.055 | 0.124 | Bronchodilator | 0.124 0.042 CID_154699705 0.12 0.044 CID_154699496 | CID_154699705 | |
| 0.095 | 0.042 | 0.123 | Carbonic anhydrase VI inhibitor | 0.123 0.028 CID_154699705 0.123 0.028 CID_154699496 | CID_154699496 | |
| 0.195 | 0.145 | 0.195 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.094 | 0.045 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 CID_154699705 0.111 0.03 CID_154699496 | CID_154699496 | |
| 0.069 | 0.024 | 0.069 | Prostaglandin E2 antagonist | 0.047 0.039 CID_154699496 | ||
| 0.074 | 0.032 | 0.086 | Glutamate (mGluR6) antagonist | 0.075 0.032 CID_154699705 0.086 0.019 CID_154699496 | CID_154699496 | |
| 0.051 | 0.01 | 0.14 | Prostaglandin agonist | 0.14 0.004 CID_154699705 0.14 0.004 CID_154699496 | CID_154699496 | |
| 0.097 | 0.058 | 0.097 | Prolactin inhibitor | |||
| 0.179 | 0.141 | 0.417 | Cardiotonic | 0.26 0.075 CID_154699705 0.417 0.026 CID_154699496 | CID_154699496 | |
| 0.048 | 0.013 | 0.048 | Integrin alpha2 antagonist | 0.034 0.032 CID_154699705 | ||
| 0.175 | 0.141 | 0.191 | Hypoglycemic | 0.191 0.121 CID_154699705 0.191 0.122 CID_154699496 | CID_154699496 | |
| 0.044 | 0.018 | 0.044 | Retinoid X receptor antagonist | |||
| 0.03 | 0.006 | 0.03 | CC chemokine 8 receptor antagonist | 0.025 0.011 CID_154699705 0.025 0.011 CID_154699496 | ||
| 0.033 | 0.011 | 0.048 | Prostaglandin EP2 agonist | 0.048 0.006 CID_154699705 0.048 0.006 CID_154699496 | CID_154699496 | |
| 0.074 | 0.053 | 0.074 | Vanilloid 4 agonist | 0.071 0.06 CID_154699705 0.071 0.06 CID_154699496 | ||
| 0.065 | 0.044 | 0.065 | Neutrophil collagenase inhibitor | |||
| 0.072 | 0.054 | 0.076 | Glutamate dehydrogenase inhibitor | 0.076 0.049 CID_154699705 0.076 0.049 CID_154699496 | CID_154699496 | |
| 0.027 | 0.011 | 0.037 | Prostaglandin F2 alpha agonist | 0.037 0.006 CID_154699705 0.037 0.006 CID_154699496 | CID_154699496 | |
| 0.021 | 0.005 | 0.034 | Thromboxane A2 agonist | 0.034 0.003 CID_154699705 0.034 0.003 CID_154699496 | CID_154699496 | |
| 0.026 | 0.011 | 0.026 | Alpha 2d adrenoreceptor agonist | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) agonist | |||
| 0.042 | 0.027 | 0.042 | Kainate receptor agonist | 0.04 0.032 CID_154699705 0.04 0.032 CID_154699496 | ||
| 0.026 | 0.011 | 0.026 | Prostaglandin EP1 antagonist | |||
| 0.028 | 0.015 | 0.028 | Integrin alpha2beta1 antagonist | |||
| 0.148 | 0.136 | 0.16 | Insulin sensitizer | 0.16 0.119 CID_154699705 | CID_154699705 | |
| 0.035 | 0.023 | 0.035 | Retinoid X alpha receptor antagonist | |||
| 0.056 | 0.045 | 0.056 | Carbonic anhydrase stimulant | |||
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | 0.029 0.027 CID_154699705 0.029 0.027 CID_154699496 | ||
| 0.032 | 0.022 | 0.036 | Glutamate (mGluR3) agonist | 0.031 0.026 CID_154699705 0.036 0.015 CID_154699496 | CID_154699496 | |
| 0.03 | 0.021 | 0.03 | Trypsin II inhibitor | |||
| 0.037 | 0.03 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.071 | 0.067 | 0.071 | Cell adhesion molecule inhibitor | |||
| 0.033 | 0.03 | 0.033 | AMPA receptor agonist | |||
| 0.021 | 0.019 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_154699705 0.027 0.008 CID_154699496 | CID_154699496 | |
| 0.084 | 0.083 | 0.108 | Carbonic anhydrase III inhibitor | 0.108 0.054 CID_154699705 0.108 0.054 CID_154699496 | CID_154699496 | |
| 0.01 | 0.009 | 0.023 | Thromboxane agonist | 0.023 0.004 CID_154699705 0.023 0.004 CID_154699496 | CID_154699496 | |
| 0.034 | 0.035 | 0.04 | Glucose-6-phosphate dehydrogenase inhibitor | 0.04 0.021 CID_154699705 0.04 0.021 CID_154699496 | CID_154699496 | |
| 0.019 | 0.022 | 0.034 | Prostaglandin E2 agonist | 0.034 0.009 CID_154699705 0.034 0.009 CID_154699496 | CID_154699496 | |
| 0.13 | 0.133 | 0.2 | Hepatoprotectant | 0.2 0.065 CID_154699705 0.2 0.065 CID_154699496 | CID_154699496 | |
| 0.043 | 0.051 | 0.075 | Carbonic anhydrase II inhibitor | 0.075 0.027 CID_154699705 | CID_154699705 | |
| 0.186 | 0.2 | 0.293 | Apoptosis antagonist | 0.293 0.09 CID_154699705 0.276 0.103 CID_154699496 | CID_154699705 | |
| 0.043 | 0.065 | 0.081 | Carbonic anhydrase inhibitor | 0.081 0.035 CID_154699705 | CID_154699705 | |
| 0.112 | 0.138 | 0.163 | Arachidonic acid antagonist | 0.163 0.073 CID_154699705 0.163 0.073 CID_154699496 | CID_154699496 | |
| 0.048 | 0.074 | 0.061 | Nitric oxide donor | 0.057 0.055 CID_154699705 0.061 0.047 CID_154699496 | CID_154699496 | |
| 0.108 | 0.135 | 0.157 | Farnesoid X receptor antagonist | 0.157 0.045 CID_154699705 0.157 0.045 CID_154699496 | CID_154699496 | |
| 0.024 | 0.055 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.029 CID_154699705 0.032 0.029 CID_154699496 | CID_154699496 | |
| 0.218 | 0.251 | 0.404 | Apoptosis agonist | 0.404 0.112 CID_154699705 0.342 0.144 CID_154699496 | CID_154699705 | |
| 0.02 | 0.059 | 0.041 | Farnesoid X receptor agonist | 0.041 0.023 CID_154699705 | CID_154699705 | |
| 0.11 | 0.151 | 0.151 | Adenylate cyclase stimulant | 0.151 0.06 CID_154699705 0.151 0.06 CID_154699496 | CID_154699496 | |
| 0.111 | 0.154 | 0.17 | Nitric oxide antagonist | 0.16 0.088 CID_154699705 0.17 0.081 CID_154699496 | CID_154699496 | |
| 0.047 | 0.093 | 0.071 | Lipocortins synthesis agonist | 0.071 0.02 CID_154699705 0.071 0.02 CID_154699496 | CID_154699496 | |
| 0.173 | 0.226 | 0.287 | Immunosuppressant | 0.287 0.124 CID_154699705 0.287 0.123 CID_154699496 | CID_154699496 | |
| 0.071 | 0.131 | 0.103 | DNA polymerase I inhibitor | 0.103 0.083 CID_154699705 0.103 0.083 CID_154699496 | CID_154699496 | |
| 0.073 | 0.138 | 0.093 | Toll-Like receptor 4 antagonist | 0.093 0.082 CID_154699705 0.093 0.082 CID_154699496 | CID_154699496 | |
| 0.147 | 0.23 | 0.253 | Transcription factor NF kappa B inhibitor | 0.221 0.15 CID_154699705 0.253 0.125 CID_154699496 | CID_154699496 | |
| 0.065 | 0.156 | 0.121 | AMP-activated protein kinase stimulant | 0.121 0.048 CID_154699705 0.121 0.048 CID_154699496 | CID_154699496 | |
| 0.098 | 0.223 | 0.168 | Immunostimulant | 0.168 0.14 CID_154699705 | CID_154699705 | |
| 0.062 | 0.187 | 0.103 | Microtubule formation inhibitor | 0.103 0.085 CID_154699705 0.103 0.085 CID_154699496 | CID_154699496 | |
| 0.082 | 0.229 | 0.166 | Growth hormone agonist | 0.166 0.075 CID_154699705 0.166 0.075 CID_154699496 | CID_154699496 | |
| 0.114 | 0.296 | 0.192 | Cholesterol antagonist | 0.192 0.172 CID_154699705 0.192 0.172 CID_154699496 | CID_154699496 | |
| 0.169 | 0.374 | 0.27 | Caspase 9 stimulant | 0.27 0.228 CID_154699705 0.27 0.228 CID_154699496 | CID_154699496 | |
| 0.072 | 0.325 | 0.301 | Vasodilator | 0.301 0.048 CID_154699705 | CID_154699705 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |